| 6/14/26 |
Johnson & Johnson (JNJ) |
Tecvayli for Multiple Myeloma (MM) |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 6/14/26 |
Bristol Myers Squibb (BMY) |
Revlimid for Multiple Myeloma (MM) |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 6/14/26 |
Eli Lilly and Company (LLY) |
Jaypirca for Non-Hodgkin's Lymphoma (NHL) |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 6/14/26 |
Eli Lilly and Company (LLY) |
Jaypirca for Chronic Lymphocytic Leukemia (CLL)/Small Cell Lymphocytic Lymphoma (SLL) |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 6/13/26 |
Johnson & Johnson (JNJ) |
Darzalex Faspro for Multiple Myeloma (MM) |
Subscribers Only |
Subscribers Only |
Subscribers Only |